Aripiprazole for the Management of Antipsychotic-Induced Hyperprolactinemia A Retrospective Case Series.

Conclusions: Hyperprolactinemia is frequently observed in patients treated with antipsychotic medications. Low-dose treatment with aripiprazole may offer a relatively rapid relief from sustained hyperprolactinemia and associated adverse effects even after a long-acting injectable is discontinued.
PMID: 31999895 [PubMed - in process]

Source: The Primary Care Companion for CNS Disorders - January 31, 2020 Category: Primary Care Tags: Prim Care Companion CNS Disord Source Type: research